project id: TCGA-PRAD; case submitter id: TCGA-EJ-5507; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 54; days to birth: -19759; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1956; age at diagnosis: 19759; ajcc clinical m: M0; ajcc clinical t: T2c; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1457.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 38.0; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.4; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-EJ-5507-01A-01; percent lymphocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent tumor cells: 55.0; percent tumor nuclei: 60.0;